{"entity":{"type":"insider","cik":"0001488774","url":"/insider/0001488774","json_url":"/insider/0001488774.json","name":"Clifton R. LaDuane","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":33,"first":"2010-04-08","last":"2025-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Clifton R. LaDuane","source":"filing","n_filings":33,"first_seen":"2010-04-08","last_seen":"2025-02-14"}],"transactions":[{"id":4212382,"accession":"0001437749-25-004068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-004068","line_url":"/filing/0001437749-25-004068#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":7.861,"price_display":"7.86","price_state":"stated","total_value":86471.0,"total_display":"86,471.00","total_whole":"86,471","shares_owned_after":51361.0,"shares_owned_after_display":"51,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":2184672,"accession":"0001437749-24-022939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-022939","line_url":"/filing/0001437749-24-022939#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":13540.0,"total_display":"13,540.00","total_whole":"13,540","shares_owned_after":18469.0,"shares_owned_after_display":"18,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-17","scope":"insider"},{"id":8590197,"accession":"0001437749-23-025317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-025317","line_url":"/filing/0001437749-23-025317#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.9591,"price_display":"4.96","price_state":"stated","total_value":4959.1,"total_display":"4,959.10","total_whole":"4,959","shares_owned_after":15309.0,"shares_owned_after_display":"15,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider"},{"id":8685875,"accession":"0001437749-23-015140","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-23-015140","line_url":"/filing/0001437749-23-015140","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2740.0,"shares_display":"2,740","price_per_share":4.949615145985401,"price_display":"4.95","price_state":"stated","total_value":13561.9455,"total_display":"13,561.95","total_whole":"13,562","shares_owned_after":13053.0,"shares_owned_after_display":"13,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-18","scope":"insider","n_lines":3},{"id":7902125,"accession":"0001437749-23-006277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-006277","line_url":"/filing/0001437749-23-006277#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1725.0,"shares_display":"1,725","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":7158.75,"total_display":"7,158.75","total_whole":"7,159","shares_owned_after":11002.0,"shares_owned_after_display":"11,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider"},{"id":8589993,"accession":"0001437749-23-001060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-001060","line_url":"/filing/0001437749-23-001060","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":635.0,"shares_display":"635","price_per_share":5.810748031496063,"price_display":"5.81","price_state":"stated","total_value":3689.825,"total_display":"3,689.82","total_whole":"3,690","shares_owned_after":9252.0,"shares_owned_after_display":"9,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-13","scope":"insider","n_lines":2},{"id":6897299,"accession":"0001437749-22-023512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-22-023512","line_url":"/filing/0001437749-22-023512","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.9812,"price_display":"5.98","price_state":"stated","total_value":5981.2,"total_display":"5,981.20","total_whole":"5,981","shares_owned_after":7709.0,"shares_owned_after_display":"7,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider","n_lines":2},{"id":6273655,"accession":"0001437749-22-012932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-012932","line_url":"/filing/0001437749-22-012932#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.9992,"price_display":"5.00","price_state":"stated","total_value":5999.04,"total_display":"5,999.04","total_whole":"5,999","shares_owned_after":6440.0,"shares_owned_after_display":"6,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-18","scope":"insider"},{"id":5546484,"accession":"0001437749-21-027098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-027098","line_url":"/filing/0001437749-21-027098#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":510.0,"shares_display":"510","price_per_share":8.29,"price_display":"8.29","price_state":"stated","total_value":4227.9,"total_display":"4,227.90","total_whole":"4,228","shares_owned_after":5240.0,"shares_owned_after_display":"5,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":4156790,"accession":"0001437749-21-022841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-022841","line_url":"/filing/0001437749-21-022841#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215.0,"shares_display":"215","price_per_share":9.38,"price_display":"9.38","price_state":"stated","total_value":2016.7,"total_display":"2,016.70","total_whole":"2,017","shares_owned_after":4730.0,"shares_owned_after_display":"4,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-09-29","scope":"insider"},{"id":4545973,"accession":"0001437749-21-022431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-022431","line_url":"/filing/0001437749-21-022431#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":935.0,"shares_display":"935","price_per_share":8.5865,"price_display":"8.59","price_state":"stated","total_value":8028.3775,"total_display":"8,028.38","total_whole":"8,028","shares_owned_after":4515.0,"shares_owned_after_display":"4,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-20","scope":"insider"},{"id":5359437,"accession":"0001437749-21-021308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-021308","line_url":"/filing/0001437749-21-021308#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230.0,"shares_display":"230","price_per_share":9.105,"price_display":"9.10","price_state":"stated","total_value":2094.15,"total_display":"2,094.15","total_whole":"2,094","shares_owned_after":3580.0,"shares_owned_after_display":"3,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-01","scope":"insider"},{"id":5413729,"accession":"0001437749-21-015562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-015562","line_url":"/filing/0001437749-21-015562#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75.0,"shares_display":"75","price_per_share":14.11,"price_display":"14.11","price_state":"stated","total_value":1058.25,"total_display":"1,058.25","total_whole":"1,058","shares_owned_after":3350.0,"shares_owned_after_display":"3,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-24","scope":"insider"},{"id":5388800,"accession":"0001437749-21-013577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-013577","line_url":"/filing/0001437749-21-013577#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":9.85,"price_display":"9.85","price_state":"stated","total_value":1477.5,"total_display":"1,477.50","total_whole":"1,478","shares_owned_after":3275.0,"shares_owned_after_display":"3,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-27","scope":"insider"},{"id":3265375,"accession":"0001437749-20-018766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-018766","line_url":"/filing/0001437749-20-018766#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.839,"price_display":"0.84","price_state":"stated","total_value":839.0,"total_display":"839.00","total_whole":"839","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-26","scope":"insider"},{"id":2524276,"accession":"0001437749-20-018274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-018274","line_url":"/filing/0001437749-20-018274#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.695,"price_display":"0.70","price_state":"stated","total_value":1390.0,"total_display":"1,390.00","total_whole":"1,390","shares_owned_after":49000.0,"shares_owned_after_display":"49,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider"},{"id":2571912,"accession":"0001437749-20-012894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-012894","line_url":"/filing/0001437749-20-012894#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":0.1923,"price_display":"0.19","price_state":"stated","total_value":288.45,"total_display":"288.45","total_whole":"288","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-11","scope":"insider"},{"id":3141815,"accession":"0001437749-20-011741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-011741","line_url":"/filing/0001437749-20-011741#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11500.0,"shares_display":"11,500","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":2104.5,"total_display":"2,104.50","total_whole":"2,105","shares_owned_after":45500.0,"shares_owned_after_display":"45,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-26","scope":"insider"},{"id":2608790,"accession":"0001437749-20-006118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-006118","line_url":"/filing/0001437749-20-006118#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.2182,"price_display":"0.22","price_state":"stated","total_value":218.2,"total_display":"218.20","total_whole":"218","shares_owned_after":34000.0,"shares_owned_after_display":"34,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-25","scope":"insider"},{"id":2907215,"accession":"0001437749-20-004949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-004949","line_url":"/filing/0001437749-20-004949#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.2513,"price_display":"0.25","price_state":"stated","total_value":2010.4,"total_display":"2,010.40","total_whole":"2,010","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-11","filed_date":"2020-03-12","scope":"insider"},{"id":8333218,"accession":"0001437749-19-025002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-19-025002","line_url":"/filing/0001437749-19-025002","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12250.0,"shares_display":"12,250","price_per_share":0.41710816326530614,"price_display":"0.42","price_state":"stated","total_value":5109.575,"total_display":"5,109.58","total_whole":"5,110","shares_owned_after":22750.0,"shares_owned_after_display":"22,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2019-12-30","scope":"insider","n_lines":3},{"id":8333091,"accession":"0001437749-19-019061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-019061","line_url":"/filing/0001437749-19-019061#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3650.0,"shares_display":"3,650","price_per_share":0.7452,"price_display":"0.75","price_state":"stated","total_value":2719.98,"total_display":"2,719.98","total_whole":"2,720","shares_owned_after":12750.0,"shares_owned_after_display":"12,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-25","scope":"insider"},{"id":8079522,"accession":"0001437749-19-018489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-19-018489","line_url":"/filing/0001437749-19-018489","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.885088,"price_display":"0.89","price_state":"stated","total_value":4425.44,"total_display":"4,425.44","total_whole":"4,425","shares_owned_after":9100.0,"shares_owned_after_display":"9,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-16","scope":"insider","n_lines":2},{"id":8368794,"accession":"0001437749-19-018218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-018218","line_url":"/filing/0001437749-19-018218#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.9452,"price_display":"0.95","price_state":"stated","total_value":472.6,"total_display":"472.60","total_whole":"473","shares_owned_after":4100.0,"shares_owned_after_display":"4,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-11","scope":"insider"},{"id":8683880,"accession":"0001437749-19-018003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-018003","line_url":"/filing/0001437749-19-018003#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850.0,"shares_display":"850","price_per_share":0.7674,"price_display":"0.77","price_state":"stated","total_value":652.29,"total_display":"652.29","total_whole":"652","shares_owned_after":3600.0,"shares_owned_after_display":"3,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-06","scope":"insider"},{"id":6243464,"accession":"0001437749-18-018208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-018208","line_url":"/filing/0001437749-18-018208#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":2.5414,"price_display":"2.54","price_state":"stated","total_value":1651.91,"total_display":"1,651.91","total_whole":"1,652","shares_owned_after":2750.0,"shares_owned_after_display":"2,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-11","filed_date":"2018-10-11","scope":"insider"},{"id":6839833,"accession":"0001437749-18-011084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-011084","line_url":"/filing/0001437749-18-011084#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525.0,"shares_display":"525","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":3202.5,"total_display":"3,202.50","total_whole":"3,203","shares_owned_after":2100.0,"shares_owned_after_display":"2,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-01","scope":"insider"},{"id":4880276,"accession":"0001437749-17-016324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-016324","line_url":"/filing/0001437749-17-016324#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.775,"price_display":"3.78","price_state":"stated","total_value":1132.5,"total_display":"1,132.50","total_whole":"1,133","shares_owned_after":1575.0,"shares_owned_after_display":"1,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-25","scope":"insider"},{"id":4429068,"accession":"0001437749-17-011574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-011574","line_url":"/filing/0001437749-17-011574#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275.0,"shares_display":"275","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":907.5,"total_display":"907.50","total_whole":"908","shares_owned_after":1275.0,"shares_owned_after_display":"1,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-21","scope":"insider"},{"id":5265503,"accession":"0001437749-17-005323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-005323","line_url":"/filing/0001437749-17-005323","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (CFO, Secretary & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.24369,"price_display":"4.24","price_state":"stated","total_value":4243.69,"total_display":"4,243.69","total_whole":"4,244","shares_owned_after":900.0,"shares_owned_after_display":"900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-24","filed_date":"2017-03-27","scope":"insider","n_lines":2},{"id":9013256,"accession":"0001140361-11-044417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-044417","line_url":"/filing/0001140361-11-044417#line-1","is_derivative":false,"issuer_cik":"0000061004","issuer_name":"LGL GROUP INC","issuer_ticker":"LGL","issuer_name_source":null,"issuer_url":"/issuer/0000061004","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51.0,"shares_display":"51","price_per_share":7.7,"price_display":"7.70","price_state":"stated","total_value":392.7,"total_display":"392.70","total_whole":"393","shares_owned_after":3606.0,"shares_owned_after_display":"3,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-31","filed_date":"2011-09-01","scope":"insider"},{"id":8886149,"accession":"0001140361-11-028682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-028682","line_url":"/filing/0001140361-11-028682#line-1","is_derivative":false,"issuer_cik":"0000061004","issuer_name":"LGL GROUP INC","issuer_ticker":"LGL","issuer_name_source":null,"issuer_url":"/issuer/0000061004","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":11.15,"price_display":"11.15","price_state":"stated","total_value":557.5,"total_display":"557.50","total_whole":"558","shares_owned_after":3555.0,"shares_owned_after_display":"3,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-19","scope":"insider"},{"id":7627051,"accession":"0001193805-10-001022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-10-001022","line_url":"/filing/0001193805-10-001022#line-1","is_derivative":false,"issuer_cik":"0000061004","issuer_name":"LGL GROUP INC","issuer_ticker":"LGL","issuer_name_source":null,"issuer_url":"/issuer/0000061004","owner_cik":"0001488774","owner_name":"Clifton R. LaDuane","owner_display_name":"Clifton R. LaDuane","owner_url":"/insider/0001488774","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":1240.0,"total_display":"1,240.00","total_whole":"1,240","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-07","filed_date":"2010-04-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":40,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Officer (CFO & Treasurer)","n_filings":30,"first_seen":"2017-03-27","last_seen":"2025-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000061004","name":"LGL GROUP INC","url":"/issuer/0000061004","role":"Officer (Chief Accounting Officer)","n_filings":3,"first_seen":"2010-04-08","last_seen":"2011-09-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001488774","retrieved_at":"2026-08-23T04:29:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}